T1	Participants 64 68	dogs
T2	Participants 174 282	dogs that presented with mild to severe congestive heart failure (New York Heart Association stage II to IV)
T3	Participants 470 556	142 client-owned dogs and was conducted in 20 locations in France, Belgium and Germany
T4	Participants 558 622	Dogs of various breed, age and weight were included in the study
T5	Participants 1049 1165	dogs presenting with pulmonary oedema and/or ascites, supraventricular tachyarrhythmia and/or dilated cardiomyopathy
